Medical Developments International Limited (ASX:MVP)

Market Cap	53.51M -25.2%
Revenue (ttm)	42.57M +9.0%
Net Income	626.00K +566.0%
EPS	0.01 +562.5%
Shares Out	112.66M
PE Ratio	89.62
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	71,557
Open	0.4850
Previous Close	0.4750
Day's Range	0.4750 - 0.5000
52-Week Range	0.3650 - 0.7650
Beta	1.41
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About ASX:MVP

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow mete...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 68
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: MVP

Financial Performance

In fiscal year 2026, ASX:MVP's revenue was 42.57 million, an increase of 8.99% compared to the previous year's 39.06 million. Earnings were 626,000, an increase of 565.96%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 21, 2026

Data Sources Report a data error